Titel

Merkliste
1 Ergebnisse

Mortality risk in patients with CVD and hypertension—Advanc..:

Sebastian Cremer (11592273) ; Lisa Pilgram (6801548) ; Alexander Berkowitsch (5774657)...
https://figshare.com/articles/figure/Mortality_risk_in_patients_with_CVD_and_hypertension_Advanced_disease_/16847979. , 2021

Link: https://doi.org/10.1371/journal.pone.0258684.g002

RT Journal
T1 <Title>Mortality risk in patients with CVD and hypertension—Advanced disease</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16847979&Exemplar=1&LAN=DE
				
A1 Sebastian Cremer (11592273)
A1 Lisa Pilgram (6801548)
A1 Alexander Berkowitsch (5774657)
A1 Melanie Stecher (6372083)
A1 Siegbert Rieg (445802)
A1 Mariana Shumliakivska (11592276)
A1 Denisa Bojkova (8068613)
A1 Julian Uwe Gabriel Wagner (11592279)
A1 Galip Servet Aslan (11592282)
A1 Christoph Spinner (9436070)
A1 Guillermo Luxán (9084065)
A1 Frank Hanses (148604)
A1 Sebastian Dolff (2591221)
A1 Christiane Piepel (11592285)
A1 Clemens Ruppert (33937)
A1 Andreas Guenther (33941)
A1 Maria Madeleine Rüthrich (11592288)
A1 Jörg Janne Vehreschild (5749058)
A1 Kai Wille (6164420)
A1 Martina Haselberger (10265459)
A1 Hanno Heuzeroth (6885524)
A1 Arne Hansen (54605)
A1 Thomas Eschenhagen (168044)
A1 Jindrich Cinatl (23848)
A1 Sandra Ciesek (345033)
A1 Stefanie Dimmeler (134234)
A1 Stefan Borgmann (11592291)
A1 Andreas Zeiher (4330300)
YR 2021
K1 Medicine
K1 Cell Biology
K1 Molecular Biology
K1 Pharmacology
K1 Biotechnology
K1 Immunology
K1 Cancer
K1 Science Policy
K1 Mental Health
K1 Infectious Diseases
K1 significantly lower incidence
K1 significantly increased risk
K1 meier analysis revealed
K1 human lung samples
K1 ace2 expression levels
K1 ace2 )
K1 drugs
K1 59 &# 8211
K1 43 &# 8211
K1 021 )
K1 procalcitonin
K1 mortality predicting threshold
K1 4 %) compared
K1 largest european covid
K1 inflammatory markers crp
K1 converting enzyme inhibitor
K1 angiotensin receptor blocker
K1 3 %
K1 p
K1 001 )
K1 neutrophils
K1 xlink "> patients
K1 xlink ">
K1 reduced markers
K1 inflammatory activation
K1 decreased mortality
K1 uncomplicated phase
K1 received neither
K1 patients using
K1 patients taking
K1 mainly driven
K1 hypertension enrolled
K1 early phase
K1 disease severity
K1 data suggest
K1 critical course
K1 cardiovascular comorbidities
K1 2 %)
K1 049 )
K1 034 )
JF https://figshare.com/articles/figure/Mortality_risk_in_patients_with_CVD_and_hypertension_Advanced_disease_/16847979
LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0258684.g002
DO https://doi.org/10.1371/journal.pone.0258684.g002
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)